Dekker, A.W.

patient donor lymphoblastic leukemia leukemia adult group study lymphoblastic relapse transplantation marrow blood treatment result remission chemotherapy outcome sibling adult patients analysis survival allo-sct allogeneic poor-risk sibling donor standard-risk table cell transplantation transplant induction center no-donor group trial donor group no-donor disease fication consolidation protocol 2 years diagnosis figure intensi therapy standard-risk patients netherland methotrexate autologous sct donor availability effect maintenance hovon classi fied autologou marrow transplantation number allosct fi rst 5 years toxicity fi rst cr intensi fication chemotherapy bone marrow transplant availability bone marrow transplantation relapse rate incidence hematology range mortality multivariable analysis signi ficantly factor department graft marrow donor program cornelissen interval prognostic volume